Early Access — free while we kick the tires
EdgarHawk

Catelani Michael

President, COO, & CFO

Officer
1 filing analyzed · 1 company · Latest 2025-01-15

Companies

Company Buys Sells Direction
Anixa Biosciences Inc ANIX 1 0 Net buying

Activity

January 2025
2025-01-15 Anixa Biosciences Inc ANIX
medium
Buy
9,289 shares
$19,971
Significance 4/10

ANIX President/COO/CFO buys 9,289 shares at $2.15; stock down -54.6% from 52-week high, company unprofitable with $-3.3M net income.

Michael Catelani (President, COO, & CFO) purchased 9,289 shares at $2.15 on 2025-01-15, increasing his holdings from 35,211 to 44,500 shares (+26.4%). The transaction occurs as ANIX trades at $2.28, having declined -54.6% from its 52-week high of $5.02. Fundamentally, the company remains unprofitable with net income of $-3.3M on quarterly revenue of $210.0K, and flat annual revenue growth (FY vs prior FY: +0.0%). Among his same-ticker history at ANIX, Catelani's prior buy on 2024-06-07 achieved a 90-day return of +40.0%, but his earlier purchase on 2023-07-20 returned -10.2% over 90 days—a mixed record that provides limited directional evidence. The timing of this buy, amid significant stock depreciation and operational losses, presents limited conviction signal; investors should monitor whether near-term fundamentals improve or whether execution challenges persist.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access